Dexamethasone sodium phosphate 0.1%; oph soln; contains benzalkonium chloride. Initial therapy: 1 or 2 drops in conjunctival sac every hour during the day and every two hours during the night. When ...
The approval was based on data from 2 vehicle-controlled Phase 3 trials. The Food and Drug Administration (FDA) has approved Dextenza (dexamethasone ophthalmic insert; Ocular Therapeutix) for the ...
7-day levofloxacin/dexamethasone eye drops as effective as standard treatment after cataract surgery
Santen EMEA and NTC are delighted to announce that the results of their phase III clinical study, LEADER7, have been published in Eye. The study demonstrated for the ...
Please provide your email address to receive an email when new articles are posted on . High visualization, ease of use and greater pain reduction for up to 30 days after cataract surgery led to ...
Optifye Therapeutics has struck a deal with DelSiTech for controlled-release dexamethasone eye drops. The exclusive license agreement covers a candidate that uses DelSiTech Silica Matrix technology to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback